Patent · US Active

Gene signatures for cancer prognosis

US11174517B2 · kind B2 · utility

2Cited by

16References

7Claims

0Family size

Assignee

Myriad Genetics, Inc. · US

Inventors

Steven Stone · Salt Lake City, US
Alexander Gutin · Salt Lake City, US
Julia Reid · Salt Lake City, US

Key dates

Filing date	Nov 11, 2016
Grant date	Nov 16, 2021
Priority date	—
Expiry date	Dec 18, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.